Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Curr Drug Deliv ; 15(7): 1064-1071, 2018.
Artículo en Inglés | MEDLINE | ID: mdl-29318970

RESUMEN

BACKGROUND: PnPP-19 is a 19-amino-acid synthetic peptide previously described as a novel drug for the treatment of erectile dysfunction. OBJECTIVE: The aim of this work was to evaluate the physicochemical properties of cationic transfersomes containing PnPP-19 and the skin permeation of free PnPP-19 and PnPP-19-loaded transfersomes. METHODS: Three different liposomal preparation methods were evaluated. Cationic transfersomes contained egg phosphatidyl choline: stearylamine (9:1 w/w) and Tween 20 (84.6:15.4 lipid:Tween, w/w). Lipid concentration varied from 20 to 40 mM. We evaluated the entrapment percentage, mean diameter, zeta potential and stability at 4 °C of the formulations. The skin permeation assays were performed with abdominal human skin using Franz diffusion cell with 3 cm2 diffusion area at 32 °C and a fluorescent derivative of the peptide, containing 5-TAMRA, bound to PnPP-19 C-terminal region, where an extra lysine was inserted. RESULTS: Our results showed variable entrapment efficiencies, from 6% to 30%, depending on the preparation method and the lipid concentration used. The reverse phase evaporation method using a total lipid concentration equal to 40 mM led to the best entrapment percentage (30.2 + 4.5%). Free PnPP-19 was able to permeate skin at a rate of 10.8 ng/cm2/h. However, PnPP-19 was specifically hydrolyzed by skin proteases, generating a fragment of 15 amino acid residues. Encapsulated PnPP-19 permeated the skin at a rate of 19.8 ng/cm2/h. CONCLUSION: The encapsulation of PnPP-19 in cationic transfersomes protected the peptide from degradation, favoring its topical administration.


Asunto(s)
Péptidos/administración & dosificación , Péptidos/química , Absorción Cutánea , Administración Cutánea , Adulto , Aminas/administración & dosificación , Aminas/química , Disfunción Eréctil/tratamiento farmacológico , Femenino , Humanos , Técnicas In Vitro , Liposomas , Masculino , Persona de Mediana Edad , Fosfatidilcolinas/administración & dosificación , Fosfatidilcolinas/química , Polisorbatos/administración & dosificación , Polisorbatos/química , Rodaminas/administración & dosificación , Rodaminas/química , Piel/metabolismo
2.
Biomed Pharmacother ; 89: 268-275, 2017 May.
Artículo en Inglés | MEDLINE | ID: mdl-28235689

RESUMEN

The use of nanoparticles for diagnostic approaches leads to higher accumulation in the targeting tissue promoting a better signal-to-noise ratio and consequently, early tumor detection through scintigraphic techniques. Such approaches have inherent advantages, including the possibility of association with a variety of gamma-emitting radionuclides available, among them, Tecnethium-99m (99mTc). 99mTc is readily conjugated with nanoparticles using chelating agents, such as diethylenetriaminepentaacetic acid (DTPA). Leveraging this approach, we synthesized polymeric micelles (PM) consisting of 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethyleneglycol)-2000] (DSPE-mPEG2000) functionalized with DTPA for radiolabeling with 99mTc. Micelles made up of DSPE-mPEG2000 and DSPE-PEG2000-DTPA had a mean diameter of ∼10nm, as measured by DLS and SAXS techniques, and a zeta potential of -2.7±1.1mV. Radiolabeled micelles exhibited high radiochemical yields and stability. In vivo assays indicated long blood circulation time (456.3min). High uptake in liver, spleen and kidneys was observed in the biodistribution and imaging studies on healthy and tumor-bearing mice. In addition, a high tumor-to-muscle ratio was detected, which increased over time, showing accumulation of the PM in the tumor region. These findings indicate that this system is a promising platform for simultaneous delivery of therapeutic agents and diagnostic probes.


Asunto(s)
Antineoplásicos/química , Antineoplásicos/farmacología , Nanopartículas/química , Neoplasias/tratamiento farmacológico , Polímeros/química , Radioisótopos/química , Animales , Línea Celular Tumoral , Sistemas de Liberación de Medicamentos/métodos , Ratones , Ratones Endogámicos BALB C , Micelas , Polietilenglicoles/química , Distribución Tisular/fisiología
3.
J Pharm Sci ; 105(7): 2194-203, 2016 07.
Artículo en Inglés | MEDLINE | ID: mdl-27290627

RESUMEN

Previous studies have demonstrated the antiherpes activity of pentyl gallate (PG), suggesting that it could be a promising candidate for the topical treatment of human herpes labialis. PG low aqueous solubility represents a major drawback to its incorporation in topical dosage forms. Hence, the feasibility of incorporating PG into nanoemulsions, the ability to penetrate the skin, to inhibit herpes simplex virus (HSV)-1 replication, and to cause dermal sensitization or toxicity were evaluated. Oil/water nanoemulsions containing 0.5% PG were prepared by spontaneous emulsification. The in vitro PG distribution into porcine ear skin after topical application of nanoemulsions was assessed, and the in vitro antiviral activity against HSV-1 replication was evaluated. Acute dermal toxicity and risk of dermal sensitization were evaluated in rat model. Nanoemulsions presented nanometric particle size (from 124.8 to 143.7 nm), high zeta potential (from -50.1 to -66.1 mV), loading efficiency above 99%, and adequate stability during 12 months. All formulations presented anti-HSV-1 activity. PG was able to reach deeper into the dermis more efficiently from the nanoemulsion F4. This formulation as well as PG were considered safe for topical use. Nanoemulsions seem to be a safe and effective approach for topically delivering PG in the treatment of human herpes labialis infection.


Asunto(s)
Antivirales/administración & dosificación , Antivirales/uso terapéutico , Ácido Gálico/análogos & derivados , Herpes Labial/tratamiento farmacológico , Administración Tópica , Animales , Antivirales/toxicidad , Estabilidad de Medicamentos , Emulsiones , Ácido Gálico/administración & dosificación , Ácido Gálico/uso terapéutico , Ácido Gálico/toxicidad , Herpesvirus Humano 1/efectos de los fármacos , Irritantes , Masculino , Ratas , Ratas Wistar , Absorción Cutánea , Enfermedades de la Piel/inducido químicamente , Enfermedades de la Piel/patología , Solubilidad , Porcinos , Replicación Viral/efectos de los fármacos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA